Salivary Histamine Levels in Patients with Oral Lichen Planus Lesions
Open Access
Abstract
Background and Objectives: An oral lichen planus (OLP) chronic lesion refers to a group of oral potentially malignant disorders (OPMDs) that still lack a proper understanding from the point of view of relevant biomarkers for diagnostics and prognosis. The aim of the study was to assess the salivary histamine levels in patients with oral lichen planus lesions. Materials and Methods: The study included a group of 76 patients with oral lichen planus. General diseases and medication taken, smoking habits, severity of pain assessed using a visual analogue scale (VAS), oral hygiene status, and duration of OLP were evaluated. ELISA diagnostics for histamines in saliva levels were assessed. Results: The histamine levels in the OLP group were higher (0.468) in comparison with the control group (0.056), without a statistically significant value p = 0.090 (Mann–Whitney U Test). The median age of 76 OLP patients was 63 years (min 22.0–max. 81), with the biological sex being 80.3% females and 15 19.7% males. The average duration of OLP lesion presence was 29.4 months (SD 37.1) and the median value was 14.5 months. The median of the VAS was 3.0. OLP assessment in accordance with the Malhotra methodology showed the highest frequency—30.3% for only two of the point areas involved and 17.1% for three points. Clinical assessment of the different OLP grades, severity, and oral site involvement and the VAS in correlation with histamine salivary levels showed a lack of statistical significance in the investigated population. Conclusions: Undertaking further research could provide further possibilities for searching for general factors in OLP development.Keywords
Funding Information
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUBZ.B150.22.100)
This publication has 48 references indexed in Scilit:
- The basics of histamine biologyAnnals of Allergy, Asthma & Immunology, 2011
- Receptive music therapy and salivary histamine secretionInflammation Research, 2009
- Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative studyJournal of the American Academy of Dermatology, 2008
- Histamine Amplifies Immune Response of Gingival FibroblastsJournal of Dental Research, 2007
- A scoring system for mucosal disease severity with special reference to oral lichen planusBritish Journal of Dermatology, 2007
- Histamine and histamine intoleranceThe American Journal of Clinical Nutrition, 2007
- Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerationsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2007
- Salivary Histamine Level as a Predictor of Periodontal Disease in Type 2 Diabetic and Non‐Diabetic SubjectsJournal of Periodontology, 2006
- Histamine and its receptorsBritish Journal of Pharmacology, 2006
- Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modificationsJournal of Oral Pathology & Medicine, 2003